Migraine vs Neuro/Psych

Discussion in 'Lundbeck' started by anonymous, Nov 15, 2019 at 7:25 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Is it true that maybe only a few Lundbeck reps will be apart of the migraine team, and Lundbeck really has no desire for any of their present salesforce to switch over? Also, is it true that the migraine reps will start around$130k +?
     

  2. anonymous

    anonymous Guest

    Yes. Many Lundbeck reps “will be apart from the company” when they leave because management F’d them.
     
  3. anonymous

    anonymous Guest

    I think it’s pretty clear what Lundbeck thinks of the current salesforce we have here lol
     
  4. anonymous

    anonymous Guest

    According to Nadia, they need people who can do the heavy lifting and not mess the launch up. How lucky are we that she brought the best with her! Evidently none of the current reps are capable of a successful launch or selling a buy and bill product
     
  5. anonymous

    anonymous Guest

    It doesn’t matter. This will be another me-too when the dust settles. I have a friend-of-the-family that is a Neurologist, and they said the once-a-month-injections are no big deal, and his/her patients don’t mind them at all. They said that all the drugs work in the class. My guess is that the pills will be big players before it’s over.

    Can’t blame Lundbeck for not wanting us to be a part of the migraine team. All we know how to do is to talk about patient profiles like mind numb robots!
     
  6. CleoFuller

    CleoFuller new user

    Joined:
    Jun 25, 2020
    Messages:
    1
    Likes Received:
    0
    Yup, it is sadly, but true(
     
  7. Davidson1987

    Davidson1987 new user

    Joined:
    Jun 30, 2020
    Messages:
    1
    Likes Received:
    0
    yep

    ahahhaha
     
  8. anonymous

    anonymous Guest

    My neighbor is also a physician and he says doing Veeva Engage lunches are not a big deal.
     
  9. anonymous

    anonymous Guest

    Wonderful news!
     
  10. anonymous

    anonymous Guest

    I would say 1 out of 50 doctors will do
    A Veeva engage with a rep.
    And actually seeing the doctor in an office call (Because of Covid) is now
    about 1 out of every 60 neurologist,
    true real access currently is terrible.
    And uptick in Covid rates now has made it worse, and In no way is offices wanting to see Rep and their manager come in for sales calls. Even the patient loads in neurology offices have been reduced and infusion Centers have also reduced patient load and rep access.
    Vyepti right now is a very hard sell as
    hardly any insurances will cover even if the PAs are completed.
    And our Vyepti connect team is a joke,
    They don’t even do the PAs for an office trying to figure out what is the benefit of using Vyepti connect for a office ??